Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Bergenbio, Biogen, Bioheng, Bio-Thera Solutions, Brii, Edesa, Eisai, Harbour Biomed, Kinarus, Neurophth, Nykode, Pharmaust, Recce, Shanghai Henlius, Shionogi, Sichuan Kelun-Biotech, Telix.